(4R)-4-(Difluoromethyl)-2,2-dimethyl-1,3-dioxolane is a difluorinated intermediate that typically used in the preparation of GDC-0077 as a potent and selective PI3K inhibitor with potential antineoplastic activity for the treatment of breast cancer.
GDC-0077 is a selective PI3K alpha inhibitor that demonstrates robust efficacy in PIK3CAmutant breast cancer models as a single agent and in combination with standard of care therapies. 
 R.Hong, et al, Cancer Res., 2018, 78(4), DOI: 10.1158/1538-7445.
UN 1993 3/PG II
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email firstname.lastname@example.org.